NovelStem International (OTCMKTS:NSTM – Get Free Report) is one of 26 publicly-traded companies in the “Retail stores, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare NovelStem International to similar businesses based on the strength of its valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.
Analyst Recommendations
This is a summary of recent ratings and price targets for NovelStem International and its competitors, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NovelStem International | 0 | 0 | 0 | 0 | N/A |
NovelStem International Competitors | 88 | 811 | 1393 | 55 | 2.60 |
As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 14.32%. Given NovelStem International’s competitors higher possible upside, analysts clearly believe NovelStem International has less favorable growth aspects than its competitors.
Risk and Volatility
Institutional & Insider Ownership
29.3% of shares of all “Retail stores, not elsewhere classified” companies are owned by institutional investors. 13.6% of NovelStem International shares are owned by insiders. Comparatively, 16.9% of shares of all “Retail stores, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares NovelStem International and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
NovelStem International | -9,166.67% | N/A | -73.18% |
NovelStem International Competitors | -25.06% | -60.82% | -0.94% |
Earnings and Valuation
This table compares NovelStem International and its competitors gross revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
NovelStem International | $10,000.00 | -$4.19 million | -0.25 |
NovelStem International Competitors | $8.78 billion | $125.13 million | 5.70 |
NovelStem International’s competitors have higher revenue and earnings than NovelStem International. NovelStem International is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Summary
NovelStem International competitors beat NovelStem International on 9 of the 10 factors compared.
NovelStem International Company Profile
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
Receive News & Ratings for NovelStem International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovelStem International and related companies with MarketBeat.com's FREE daily email newsletter.